The Influence of Hyperthyroidism on the Coagulation and on the Risk of Thrombosis

• Published in: Journal of clinical medicine 2024-03, Vol.13 (6), p.1756
• Main Authors: Antonijevic, Nebojsa, Matic, Dragan, Beleslin, Biljana, Mikovic, Danijela, Lekovic, Zaklina, Marjanovic, Marija, Uscumlic, Ana, Birovljev, Ljubica, Jakovljevic, Branko
• Format: Article
• Language: English
• Subjects: Acute phase proteins; Age; Antibodies; Anticardiolipin antibodies; Anticoagulants; Blood clot; Blood clotting disorders; Blood coagulation factors; Cardiac arrhythmia; Cardiolipin; Cardiology; Complications and side effects; Fibrin; Heart attacks; Hyperthyroidism; Hypothyroidism; Laboratories; Lupus; Membrane lipids; Normal distribution; Patients; Pulmonary embolisms; Risk factors; Statistical analysis; Thromboembolism; Thrombosis; Thyroid gland; Variance analysis; Viral antibodies
• ISSN: 2077-0383; 2077-0383
• DOI: 10.3390/jcm13061756

: Apart from the well-known fact that hyperthyroidism induces multiple prothrombotic disorders, there is no consensus in clinical practice as to the impact of hyperthyroidism on the risk of thrombosis. The aim of this study was to examine the various hemostatic and immunologic parameters in patients with hyperthyroidism. : Our study consists of a total of 200 patients comprised of 64 hyperthyroid patients, 68 hypothyroid patients, and 68 euthyroid controls. Patient thyroid status was determined with standard tests. Detailed hemostatic parameters and cardiolipin antibodies of each patient were determined. : The values of factor VIII (FVIII), the Von Willebrand factor (vWF), fibrinogen, plasminogen activator inhibitor-1 (PAI-1), and anticardiolipin antibodies of the IgM class were significantly higher in the hyperthyroid patients than in the hypothyroid patients and euthyroid controls. The rate of thromboembolic manifestations was much higher in hyperthyroid patients (6.25%) than in hypo-thyroid patients (2.9%) and euthyroid controls (1.4%). Among hyperthyroid patients with an FVIII value of ≥1.50 U/mL, thrombosis was recorded in 8.3%, while in hyperthyroid patients with FVIII value ≤ 1.50 U/mL the occurrence of thrombosis was not recorded. The incidence of atrial fibrillation (AF) was significantly higher (8.3%) in the hyperthyroid patients compared to the hypothyroid patients (1.5%) and euthyroid controls (0%). : High levels of FVIII, vWF, fibrinogen, PAI-1, and anticardiolipin antibodies along with other hemostatic factors contribute to the presence of a hypercoaguable state in patients with hyperthyroidism. The risk of occurrence of thrombotic complications is especially pronounced in patients with a level of FVIII exceeding 150% and positive anticardiolipin antibodies of the IgM class. Patients with AF are at particularly high risk of thrombotic complications due to a hyperthyroid prothrombotic milieu.